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ABSTRACT 
Purpose: To study the influence of molecular shape, conformability, net surface charge and 
tissue interaction on transscleral diffusion.   
Methods: Unfixed, porcine sclera was clamped in an Ussing chamber. Fluorophore labelled, 
neutral, albumin, dextran, or ficoll were placed in one hemi-chamber and the rate of 
transscleral diffusion was measured over 24 hours using a spectrophotometer. Experiments 
were repeated using dextrans and ficoll with positive, or negative, net surface charges.  
Fluorescence recovery after photobleaching 
 (FRAP) was undertaken to compare transscleral diffusion with diffusion through a solution. 
All molecules were 70 kDa. 
Results: Using FRAP, mean ± SD diffusion coefficient (D) was highest for albumin, 
followed by ficoll, then dextran (p = 0.0005). Positive dextrans diffused fastest, followed by 
negative, then neutral dextrans (p = 0.0005). Neutral ficoll diffused the fastest, followed by 
positive then negative ficoll (p = 0.0008). For the neutral molecules, transscleral D was 
highest for albumin, followed by dextran, then ficoll (p < 0.0001).  D was highest for 
negative ficoll, followed by neutral, then positive ficoll (p < 0.0001).  By contrast, D was 
highest for positive dextran, followed by neutral, then negative dextran (p = 0.0021).  
 Conclusions: Diffusion in free solution does not predict transscleral diffusion and the 
molecular-tissue interaction is important. Molecular size, shape, and charge may all markedly 
influence transscleral diffusion, as may conformability to a lesser degree, but  all need to be 
considered when selecting or designing drugs for transscleral delivery. 
 
 
 
 
 
 
 
 
 
 
 
 
Drugs directed against vascular endothelial growth factor (VEGF) have proven efficacy in 
some of the most common retinal diseases. The ANCHOR and MARINA studies 
demonstrated efficacy in wet age-related macular degeneration (AMD),1,2 and studies such as 
CRUISE, BRAVO3,4 and several from the DRCnet Group have shown favourable results in 
retinal vein occlusion and diabetic macular oedema. Whilst the data in these studies have led 
to improved clinical care, the need for regular intravitreal injections represents a burdensome 
regimen of treatment. A less invasive mode of delivery would have potential advantages in 
terms of reduced cost, discomfort, and complication rate.   
Systemic administration is impeded by the blood-aqueous and blood–retinal-barriers. High 
drug concentrations may be required to overcome these barriers to diffusion, with the 
attendant risk of systemic side effects.5 
A topical route would have obvious advantages. Delivery to the retina is however difficult for 
several reasons, such as lacrimation, low corneal permeability to large molecules, counter 
directional intraocular convection, and importantly the long diffusional distance.53 Blood 
flow in the conjunctiva, episclera and choroid can also reduce drug concentration.33,50  
Notwithstanding these potential difficulties, transscleral delivery has a number of potential 
advantages.6,7,8,9 The sclera has a large and accessible surface area, and a high degree of 
hydration, making it conducive to water-soluble substances. It is also hypocellular and thus 
the proteolytic enzymes are less likely to degrade drugs. 
The scleral matrix consists of collagen and elastin fibres and the arrangement of these fibres 
is thought to influence drug diffusion. The posterior scleral fibres are less tightly packed than 
the anterior sclera. The scleral fibres tend to have a lateral orientation, and this may explain 
why diffusion is slower in the transverse direction3. The proteoglycans in the scleral matrix 
are negatively charged, and this may explain why negatively charged solutes may diffuse 
faster across the scleral matrix than positively charged solutes, which may be bound to the 
negatively charged matrix.4,5 Several authors have shown that the sclera is more permeable to 
hydrophilic molecules than lipophilic ones.40-42 
Inomata studied the transscleral diffusion of radio- or dye-labelled albumin, and a 40 kDa red 
dextran following injection into the suprachoroidal space of rabbits. Both substances were 
detected in the extra-ocular tissues. Subsequent experiments demonstrated that thorotrast 
particles of 10 nm diameter were able to cross the sclera in the cynomolgus monkey, 
suggesting that the sclera contains relatively large pores.43  
These experiments suggest that it would be possible to deliver relatively large drugs across 
the sclera and in vivo experiments subsequently have provided proof in principal.  Ambati et 
al used an osmotic pump to deliver high molecular weight (MWT), fluorescently labelled IgG 
(150 kDa) across rabbit sclera.8  The pump was secured against bare sclera, and resulted in 
relevant concentrations in the choroid and retina for up to four weeks, with minimal systemic 
absorption. Further experimental studies have shown transscleral delivery of various 
macromolecules including PLGA microspheres containing an anti-VEGF RNA aptamer 
(EYE001),10 70-kDa dextrans,11 and FITC-albumin.12 Industry backed clinical trials of 
topical anti-VEGF drugs are now underway (clinicaltrials.gov identifier: NCT01362348).  
There are several drug-related factors that may influence diffusion across biological tissue, 
including MWT, shape, net surface charge, conformability, and water solubility, amongst 
others. The effect of MWT has been relatively well studied in the sclera, but there are fewer 
studies investigating surface charge, and to date no studies specifically examining the 
influence of molecular shape and conformability.  
The polysaccharides ficoll and dextran have been extensively used in renal research as 
molecular probes to demonstrate permselectivity across a glomerular membrane. They are 
used largely due to their inert nature. When comparing dextrans and ficoll to other molecules 
of an equivalent in vitro Stokes-Einstein (SE) radius both molecules are hyperpermeable, and 
it has been proposed that this is due their relative conformable nature.22 
Lavrenko et al studied the mass of ficoll, its viscosity, and their effect on the diffusion 
coefficient in the kidney.23 Bohrer et al used light scattering techniques and suggested that 
ficoll was shaped more like a sphere than a rod.24 Ohlson et al and Oliver et al reached the 
same conclusion.25,26  
Venturoli et al. reviewed the literature and concluded that ficoll also exhibits "nonideal" 
properties due to an open, deformable structure and thus that it deviates from an ideally hard 
sphere in nature.2 More recently, Fissel et al used multi-angled light scattering (MALS) to 
study the shape and conformability of ficoll. He proposed that ficoll may behave more like a 
random coil than a sphere, or it might be a mixture of both. He also considered that ficoll may 
have many intermediate shapes, or that it may have the ability to change its shape under 
pressure.27   
 Dextrans are thought to be linear, flexible molecules, with a loose, open structure, and a high 
degree of deformability, which renders them more permeable than a more rigid globular 
protein such as albumin, and indeed even more permeable than ficoll, at least with respect to 
the glomerulus.22  
These studies indicate that, in combination, dextran, ficoll and albumin serve as useful 
molecules with which to study the effect of shape and conformability on diffusion across 
tissue.   
This study explores the transscleral diffusion of dextrans, ficoll, and albumin of the same 
MWT, and compares the results to diffusion in a free solution using fluorescence techniques. 
In particular, this study investigates factors other than MWT that might influence diffusion, 
namely net surface charge, molecular shape, and the degree of molecular conformability. By 
comparing transscleral diffusion to that in free solution it is possible to determine the intrinsic 
diffusional characteristics of each molecule, and how this might change when interacting 
with scleral tissue.  Identifying factors that influence transscleral diffusion will assist in the 
design and selection of drugs that can cross the sclera to treat posterior segment disease. 
 
METHODS 
All reagents were labelled with fluorescein isothiocyanate (FITC). Neutral bovine serum 
albumin (Sigma-Aldrich, Poole, UK), neutral dextran and neutral ficoll were used to assess 
the effects of shape on diffusion. In a separate study, molecules of differing net surface 
charge were prepared, to determine the effect of charge on diffusion. Two molecules were 
selected, in case the effect of charge differed across molecules, and the results in one might 
not therefore be generalizable to others.  Neutral, cationic and anionic FITC-dextrans and 
FITC-ficoll were designed and supplied for this study by TDB Consultancy, Sweden. The 
anionic reagents were carboxymethylated (CM) and the cationic agents were prepared using a 
diethylaminoethyl (DEAE) compound. The substitution levels were 5% for CM groups and 
3-4% for DEAE groups. The same reagents were used for both transscleral diffusion, and 
diffusion in free solution. All experiments were conducted at 20oC. Ficoll, dextran, and 
albumin all had a MWT of 70 kDa. 
FREE DIFFUSION IN SOLUTION 
Fluorescence recovery after photobleaching (FRAP) was used to determine the diffusion of 
molecules in free solution, to determine the intrinsic diffusional characteristics of each 
molecule. Test molecules were prepared in PBS at concentration of 1mM. Each 1mM 
concentration of test reagent was combined with 4 different viscosities of glycerol (Sigma-
Aldrich) to create a variable viscosity gradient for the experiments. 
A mean recovery time and diffusion coefficient was calculated for each viscosity. This data 
was plotted as a scatter chart of inverse viscosity (Pa-1.s-1) against diffusion coefficient 
(cm2.s-1) and from this the diffusion coefficient in water (1.003x10-3 Pa.s at 20ºC) was 
extrapolated.    
The FITC-labelled molecules were inserted into 300µL wells (GE Healthcare, Amersham, 
UK) and FRAP was undertaken using three different bleach areas. 
For a circular bleach area the fluorescence recovery time, τd, can be calculated by a 
monoexponential fit of the recovery curve. The relationship between τd and the translational 
diffusion coefficient, D, is given in equation 1:  
1. D = γw2 / 4τd30 
Where γ is a constant and w the bleach radius.  
All experiments were undertaken using an inverted confocal laser scanning microscope 
(Leica TCS SP2 Wetzlar, Germany).  In all individual FRAP experiments the sample was 
measured using a low intensity (<1mW) continuous Ar-ion laser at 488nm through a 63x 
water immersion objective (Leica) with numerical aperture of 1.2. Ten pre-bleach scans were 
measured at low intensity, followed by 1 bleach scan in a region of interest (ROI) using the 
same laser at high power (~4mW) and then 100 post-bleach scans of the sample.31,52 This was 
repeated six times for each sample viscosity.  A bleach radius of 7.5, 10 and 12.5 µm was 
initially selected for the experiments but raw images were used to calculate the radius as 
explained later. The intensity in the ROI was monitored as a function of time during the scan 
sequence and the resulting recovery curve was fitted to a simple single-exponential model 
from which the translational diffusion coefficient was determined using equation 2:  
2. I(t) = A(1-e-kt) + C 30 
Where I is the fluorescence intensity, A is the final plateau intensity after recovery minus the 
initial intensity after bleaching, that is F∞ – F0, C is F0 and k is a time constant (τ1/2 = ln 2/k)30 
(Figure 1). A high specification software package (Origin 8, OriginLab, Northampton, USA) 
was used to facilitate calculations.  
The line scan speed for each experiment was 800 Hz and images were recorded with 512 x 
512 pixels such that the acquisition for each frame, including the bleach frame, was ~0.82 s.   
The ratio of bleach time to diffusion time was less than 1:15 for all experiments.32 A 
subtraction of background intensity was incorporated to correct for any external fluorescence 
intensity loss during the experiments.  Experiments were repeated six times for each bleach 
area, with three bleach radii per viscosity and four different viscosities per molecule. 
As shown in the literature, underestimated values for D are often obtained and can vary 
depending on bleaching spot sizes,34,35 thought to be due to long scanning times of the 
confocal laser scanning microscope when viewing fast diffusing molecules36; this was 
minimised by using the raw bleach images to obtain the bleach radius. Images extracted from 
the Leica software were analysed with a line profile using Image J (Image J 1.45s, Wayne 
Rasband, National Institute of Health, USA) across the bleach area in 10 different 
orientations going through the centre. The 10 diameters were then averaged and divided by 2 
to produce a radius used for further calculations. 
Our data for albumin were used to validate the methodology as the diffusion coefficient and 
radius of albumin are well documented in literature. Table 1 demonstrates the results for 
albumin diffusion coefficients calculated for each bleach radius at each viscosity. The plot for 
this is demonstrated in Figure 2. The gradients for these three different bleach radii were 
substituted into equation 3 below: 
3. D = KT / 6µπR 
Where D is the diffusion coefficient, K is the Boltzmann constant, T the temperature in 
Kelvin, µ the viscosity and R is the radius of the molecule. 
Experiments were conducted at 20 °C (293.15 K).  The diffusion coefficient (and 
permeability coefficient) was adjusted to 37 °C using Einstein’s relationship (equation 4), to 
allow comparison with others’ data, if required:  
4. D37 = D20 ( T37 / T20 ) (20 / 37 ) 
Where,  
D20 and D37 = diffusion coefficient at 20 °C and 37 °C (cm
2.s-1).  
T20 and T37 = absolute temperature in Kelvin at 20 °C and 37 °C. 
20 and 37 = viscosity of water at 20 °C (1.003 x10-3 Pa.s at 20 °C) and 37 °C (0.692 x10-3 
Pa.s). 
Statistical tests 
Mean values of each of the three comparison groups were tested using nonparametric 
ANOVA (Kruskal-Wallis), using SPSS (Version 20, IBM, Portsmouth, UK). Comparisons 
across two groups were undertaken using Mann-Whitney. A p value less than 0.05 was 
considered significant. 
 
TRANSSCLERAL DIFFUSION 
Species selection and tissue preparation  
Porcine eyes were selected as the most appropriate animal model. Compared to primate, 
murine, feline, and bovine sclera, porcine sclera has greater homology to human sclera.  
Studies have shown its similarity in terms of both its anatomic thickness, and ultrastructure.7 
In particular, porcine sclera has a similar collagen organisation. Since the interfibrillary 
spaces may define pore size this fact may be important when studying transscleral 
permeability. Studies in retina also suggest the pig may be an appropriate model for studies of 
human ocular diffusion.14  
The extra-ocular muscles were dissected free and the anterior segment was removed by 
cutting circumferentially behind the limbus.  The globe was then cut into two halves and the 
vitreous, episclera, and choroid were carefully dissected away using fine forceps and spring 
scissors.  The underlying RPE was carefully removed and the inner surface of the sclera was 
rubbed gently with a cotton tipped swab. The equatorial sclera was then dissected into 
multiple, full-thickness, 8 by 9 mm specimens, avoiding any scleral emmisaria. The scleral 
thickness was measured for each specimen using a digital Vernier calliper (PR5638, 
Toolspot, Tiverton, UK). In accordance with other researchers,7,14 specimens were frozen at -
80οC and then defrosted when required.  
 
Diffusion testing apparatus 
Sclera was clamped in an Ussing chamber.13 The circular interchamber aperture measured 6 
mm in diameter. The two hemi-chambers were locked together using locating screws that 
were tightened using the minimum force necessary to prevent leak, and yet preserve the 
integrity of the tissue used. Previous studies have demonstrated the integrity of tissue 
clamped in this Ussing chamber.13,15,16,17  
A small glass encased magnetic stirrer was added to each hemi-chamber. Previous studies 
have demonstrated that stirring does not increase the scleral permeability of high MWT 
compounds.18,19 The top of each hemi-chamber was sealed by insulation tape to avoid 
evaporative loss, but the tape was pierced by a needle to prevent a pressure gradient from 
building across the chambers if the fluid levels differed in any way. The samples were 
protected from light for the duration of the experiments, which were conducted at room 
temperature (20oC). 
The hemi-chamber facing the orbital surface of the sclera was filled with 1 ml of phosphate-
buffered saline (PBS; sodium chloride 137 mM, potassium chloride 2.7 mM, phosphate 
buffer 10 mM, pH 7.4 at 25°C; Sigma-Aldrich), with streptomycin 100 mg.L-1 (Sigma-
Aldrich). The other hemi-chamber was filled with 1 ml of PBS and the FITC labelled test 
molecule at 0.1 mM.  
Measurement of diffusion 
Diffusion was tested over 48 hours. The concentration in the recipient chamber was 
determined using a nanodrop spectrophotometer (Nanodrop 2000, ThermoScientific, 
Wilmington, DE), measuring absorption at 490 nm. The scleral sample was removed and 
examined to ensure it remained intact at the end of the experiment. The concentration of each 
sample was calculated from the linear portion of predetermined standard curves, using linear 
regression analysis. 
Calculation of diffusion coefficient and permeability coefficient 
The calculation of the diffusion coefficient (D)(cm2.s-1) is based on Fick’s first law (equation 
5): 
5. 𝐷 =
𝑅.𝐿
𝐴.𝐶
 
Where, 
R = diffusion flux (nanomoles.s-1) 
L = scleral thickness (cm) 
A = surface area of interchamber aperture (cm2) 
C = concentration gradient (as the concentration in the receiver chamber was typically about 
1% of that in the donor chamber, the concentration in the donor chamber was taken as the 
concentration gradient, in nanomoles/cm3) 
The relationship between diffusion coefficient (D) and permeability coefficient (P) is given 
by equation 6: 
6. 𝐷 =
𝑃.𝐿
𝐾
 
Where, 
K = partition coefficient (0.62 at ambient and body temperature)20 
L = Scleral thickness (cm).  
Statistical tests 
Mean values of each of the three comparison groups were tested using nonparametric 
ANOVA (Kruskal-Wallis test with Dunn’s multiple comparison test), using InStat 
(GraphPad, La Jolla, CA). Comparisons across two groups was undertaken using Mann-
Whitney. A p value less than 0.05 was considered significant. 
 
 
DYNAMIC LIGHT SCATTERING AND LASER DOPPLER VELOCIMETRY  
 
To establish the net surface charge of molecules, samples were analysed using a Zetasizer 
Nano ZS (Malvern Instruments Ltd., UK) that uses laser Doppler velocimetry (LDV) to 
measure the zeta potential of particles in a solution. The system passes a 633nm laser through 
the electrically charged sample to measure the velocity of particles in an applied electrical 
field of known value.  Samples were diluted in PBS to a final concentration of 5mg/1mL, to 
avoid multiple scattering, and placed in a disposable zeta cell for measurement. A 4-mW He-
Ne 633 nm laser was shone onto the sample and the intensity of light scattered at an angle of 
173° was detected by an avalanche photodiode.  
 
RESULTS 
FREE DIFFUSION IN SOLUTION 
The radius of albumin at the three different bleach radii were calculated to be 3.42, 3.31 and 
3.13 nm, giving a mean value of 3.29 ± 0.15nm. At the viscosity of water, at 20 ºC, the 
diffusion coefficients calculated from the three line equations were 6.27, 6.48 and 6.85 x 10-7 
cm2.s-1, with a mean value of 6.53 ± 0.025 x10-7 cm2s-1. These values are in agreement  to a 
published radius of 3.0, 3.5 and 3.59nm,37,38,51 and a diffusion coefficient39 in water at 25ºC of 
6.40 ± 0.40 x 10-7 cm2.s-1 (5.59 ± 0.35  x 10-7 cm2.s-1 at 20 ºC based on Einstein’s 
relationship).  The data and plot are shown in Table 1 and Figure 2 respectively.  
Tables 2 to 4 summarise the diffusion coefficients of all molecules in PBS, at 20ºC and 37 ºC. 
Figure 3 shows combined results in PBS at 20 ºC. 
Of the neutral molecules, the diffusion coefficient was highest for albumin, followed by ficoll 
and then dextran (p = 0.0005) (Figure 3).  Albumin diffusion was significantly faster than 
dextran (p = 0.002) but only marginally faster than ficoll. The difference between dextran and 
ficoll also reached significance (p = 0.002). 
Alterations in the surface charge of dextrans significantly altered the diffusion coefficient (P 
= 0.0005), but the magnitude of difference was small (Figure 3). Positive dextrans diffused 
the fastest, followed by negative then neutral dextrans.  Individual comparisons across all 
three groups were significant (all p < 0.05). 
By contrast, alteration in the surface charge of ficolls produced a large magnitude of 
difference (P = 0.0008), and the pattern of effect was exactly opposite, in that negative 
molecules diffused faster than positive molecules (Figure 3). Individual comparisons across 
all three groups were significant (all p < 0.05). 
 
TRANSCLERAL DIFFUSION 
Diffusion Coefficients 
Figure 3 shows the diffusion coefficients in sclera, alongside those in free solution.  
Of the neutral molecules, the diffusion coefficient was highest for albumin, followed by 
dextran and then ficoll (p < 0.0001).  Albumin diffusion was significantly faster than both 
ficoll and dextran (p < 0.001 for both), but the difference between dextran and ficoll did not 
reach significance. 
Positive dextrans had a higher diffusion coefficient than neutral dextrans, which were higher 
than negative dextrans (p = 0.0021).  There was a significant difference comparing positive 
and negative dextrans (p < 0.01), but the difference did not reach significance when 
comparing neutral dextrans with either positive dextrans or negative dextrans.      
Negative ficoll had a higher diffusion coefficient than neutral ficoll (p < 0.01), and positive 
ficoll (p < 0.001). Neutral ficoll had a faster diffusion than positive ficoll (p < 0.01).   
 
Permeability Coefficients 
Figure 4 shows the permeability coefficients in sclera. The results showed a similar pattern to 
the transscleral diffusion coefficients.  
The mean permeability coefficient of neutral molecules was highest for albumin, followed by 
dextran and then ficoll (p < 0.0001). The difference between albumin and dextran, and 
between albumin and ficoll were significant (p < 0.001 for both), but the difference between 
dextran and ficoll did not reach significance.  
Whereas negative ficoll showed faster diffusion across sclera than positive ficoll, the results 
were reversed in the dextran studies.  Positive dextrans had the highest mean permeability 
coefficient, followed by neutral dextrans and then negative dextrans (p = 0.0043).  Negative 
dextrans had significantly slower diffusion than both neutral dextrans (p = 0.0036) and 
positive dextrans (p = 0.0055). The difference between neutral and positive dextrans did not 
reach significance.    
The permeability coefficient of neutral ficoll was compared to that of negative ficoll and 
positive ficoll. Negative ficoll had the highest permeability coefficient, followed by neutral 
ficoll and then positive ficoll (p < 0.0001). The difference was significant across all 
intergroup comparisons (p = 0.0017 to p < 0.0001). 
 
DYNAMIC LIGHT SCATTERING AND LASER DOPPLER VELOCIMETRY  
 
Results are summarised in Table 5. As shown in this table, both the molecules designed to be 
neutral possessed a negative charge, but this was not as negative as the molecules designed to 
be negatively charged. This observation concurs with other researchers.22 It is known that 
FITC holds an approximately -1mV charge,45 hence FITC-labelled molecules are often 
slightly more anionic that unlabelled molecules, with the final charge depending on the ratio 
of labelling.  
 
DISCUSSION  
This study was designed to investigate the effect of net surface charge, shape, conformability 
and tissue interaction on the diffusion of macromolecules across the sclera. Albumin, ficoll 
and dextrans were selected as test agents not because they have therapeutic potential, but 
because their molecular configuration may offer insight into the factors that influence 
transscleral diffusion. In all cases the MWT of each molecule was 70 kDa.  
Diffusion in free solution 
Initial FRAP experiments were undertaken to determine the diffusion in free solution, 
independent of any tissue interaction. These studies were designed to show the intrinsic 
diffusional characteristics of each molecule.  Neutral albumin and ficoll had similar rates of 
diffusion, and both were faster than dextran. These diffusion coefficients predict a molecular 
radius of 3.29 nm, 3.39 nm and 5.35 nm for albumin, ficoll and dextran respectively.  
Reported values in the literature are 3.0 to 3.5 nm,37,38,51 1 to 7 nm,8 and 6.4 nm,48 
respectively. The similarity between albumin and ficoll suggest that, in solution, ficoll exists 
as a sphere.    
When dextrans were manufactured with a positive or negative charge, there was relatively 
little change in their diffusion coefficient, whereas either an anionic or cationic charge slowed 
the diffusion of ficoll to an appreciable degree. This suggests that a net surface charge may 
alter the size of ficoll, most likely changing it from a compact sphere to perhaps a branching 
dendrimer or random coil.27 This is consistent with reports showing the ficoll becomes more 
open when a negative charge is added.28 This is most likely due to the opposing negative 
electrostatic charges repelling each other, forcing the structure to open. Given that neutral 
dextrans exist in a relatively open structure, they may have been less likely to change their 
configuration in response to an altered surface charge. 
 Effect of molecular size and shape on scleral permeability 
Several authors have shown that scleral permeability declines with an increasing MWT,6,7,8,21 
but others have postulated that molecular radius is a better predictor of permeability.8 It has 
been reported that the globular protein albumin, with a MWT of 69 kDa and radius of 3.5 nm, 
has higher scleral permeability than a linear dextran of 40 kDa and 4.5 nm radius.5 Ambati et 
al also showed that rabbit sclera is more permeable to bovine serum albumin and IgG than to 
dextrans of comparable MWT.8  
These results are consistent with our findings. Our data suggest that the maximum molecular 
radius is a better predictor of scleral permeability than MWT. Hence small globular proteins 
such as albumin diffuse across the sclera more effectively than branching or linear molecules 
with significant asymmetry in their shape. 
To our knowledge, this is the first time ficoll has been used to study ocular diffusion.   Ficoll 
has however been used by several authors to investigate glomerular permselectivity.  Ventruli 
and Rippe reviewed the diffusion of dextrans, albumin and ficoll across the glomerular 
membrane of the kidney.22 Unlike the results of the present study, they noted that ficoll and 
dextran diffused quickly across the glomerulus. They speculated that this was due to the 
linear shape of dextrans, with high molecular-size-asymmetry, and the deformability of both 
dextrans and ficoll.  
It is interesting to speculate as to why the sclera behaved differently to the glomerulus, in that 
dextrans and ficoll both diffused across the sclera more slowly than albumin. The glomerular 
capillary wall is characterised by a network of small (3.7-5.5 nm) and large (10 nm) pores, 
with a thickness of 200-400 nm.22  By contrast, the sclera is composed of numerous layers of 
meshwork fibres and a mean thickness of 0.53 mm.46 Although some studies have shown that 
molecules as large as 10 nm can traverse the sclera,43  others suggest a  pores size of 5 nm.47  
Therefore, although the pore sizes may be comparable to the glomerulus, the pathlength for 
diffusion is much higher in sclera. It is possible that this entraps linear or branching 
molecules such as dextan and ficoll. Another possibility is that the large hydrostatic pressure 
gradient that exists across the glomerulus, to enable filtration, also exerts a force that 
compresses both dextran and ficoll, exploiting their conformable nature and enhancing 
clearance. Such a gradient did not exist in the present experimental set up, and would not 
exist in the context of transscleral drug delivery.   
Net surface charge  
To determine if net surface charge alters diffusion across the sclera, molecules of negative, 
neutral and positive net surface charge were manufactured.  To ensure that findings were not 
peculiar to a given molecule, both dextran and ficoll were tested. 
It is generally held that negatively charged molecules diffuse faster across biological barriers 
than positive or neutral molecules. This stems largely from the renal literature, and in 
particular, studies using ficoll. Asgeirsson et al demonstrated an increased permeability of the 
glomerular capillary wall to negatively charged carboxymethylated ficoll, relative to neutral 
ficoll.28 This occurs because the negatively charged ficoll becomes larger,28  and whilst the 
increased molecular radius might be anticipated to slow diffusion across tissue, the molecule 
instead becomes less dense and consequently more flexible (compressible), making it 
hyperpermeable across the glomerular barrier. By contrast, dextran did not show this marked 
increase in hyperpermeability when carboxymethylated. This suggests that charge has an 
indirect effect on permeability by altering the structure of the molecule and its 
conformability, rather than a direct effect as was previously assumed.  
Scleral tissue is known to have a negative charge.47 In general, this would be expected to 
slow the diffusion of positively charged molecules, which may be retained in the scleral 
substrate. Unexpectedly, this was not the case with cationic dextrans in the present study. The 
diffusion coefficient of negatively charged ficoll was very high and it is interesting to 
speculate whether or not this was simply due to the charge itself, of whether the combination 
of a negatively charged molecule and negatively charged environment somehow resulted in 
ficoll assuming its more spherical shape.  
Conclusion 
The present study investigated the effect of molecular shape, charge, and conformabilty.  Of 
the three variables studied, it seems that shape is the most critical, followed by charge, and 
then conformability.  Diffusion in free solution does not reliably predict how molecules will 
diffuse across the sclera, indicating that the molecule’s interaction with sclera tissue is 
important. An understanding of the variables that influence scleral permeability may guide 
the selection or design of drugs for transscleral drug delivery.  
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FIGURE LEGENDS 
Figure 1. The top schematic showing a typical FRAP curve. Region a is the initial 
fluorescence intensity of unbleached solution in the region of interest. Region b occurs after 
photobleaching, which reduces the measured fluorescence.  As unbleached molecules diffuse 
into the region of interest the fluorescence increases(c), which continues to show the recovery 
and once d is reached there is a stabilisation in the recovery and the curve flattens. The 
increase in fluorescence after photobleaching reflects the speed with which molecules diffuse 
into the bleached area, and can be used to determine the diffusion coefficient. The 
insert shows a representative example, using neutral albumin. 
Figure 2. The graph plots the diffusion coefficient of albumin for each bleach area and over a 
range of different viscosities. The gradient of the lines of best fit, forced through the y axis at 
0, was used to calculate the diffusion coefficient of the 70kDa albumin molecule. The mean 
predicted molecular radius of 3.29 ± 0.15nm fits with the reported size of albumin, 
suggesting that the methodology was appropriate for this, and by extension, other molecules.  
Figure 3. Graph shows the mean diffusion coefficient of all molecules in solution, calculated 
at the viscosity of water, and measured at 20οC.  The darker gray columns show the results in 
sclera, also at 20οC. Statistical comparisons are provided in the text.   
Figure 4. Graph shows the permeability coefficients of all molecules, in sclera, at 20οC. 
Statistical comparisons are detailed in the text.  
 
 
 
        
  
TABLES 
 
Table 1. Albumin diffusion coefficient in relation to viscosity and bleach radius.  
        Inverse 
viscosity   
(pa-1.s-1) 
20.03 14.01 10.82 8.77 
Radius (µm) 10.47 12.05 14.59 10.47 12.05 14.59 10.47 12.05 14.59 10.47 12.05 14.59 
Diffusion 
coefficient ± 
SD 
 x10-8 cm2s-1 
1.42 
± 
0.01 
1.30 
± 
0.08 
1.25 
± 
0.08 
0.91 
± 
0.04 
0.92 
± 
0.05 
0.87 
± 
0.05 
0.74 
± 
0.01 
0.70 
± 
0.05 
0.69 
± 
0.05 
0.58 
± 
0.02 
0.56 
± 
0.02 
0.57 
± 
0.02 
 
 
 
 
Table 2. Diffusion coefficients of neutral molecules in solution and sclera.  
N
eu
tr
al
 
M
o
le
cu
le
s 
Diffusion in Solution Transscleral Diffusion 
Diffusion 
coefficient ± 
SD, 20°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 37°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 20°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 37°C  
(x10-7 cm2s-1) 
Permeability 
coefficient ± 
SD, 20°C  
(x10-6 cm2s-1) 
Permeability 
coefficient ± 
SD, 20°C  
(x10-6 cm2s-1) 
Albumin  6.53 ± 0.025 10.01 ± 0.038  3.88 ± 2.62 6.08 ± 4.11   2.82 ± 1.30 4.15 ± 1.91  
Dextran  4.01 ± 0.065  6.15 ± 0.10  1.63 ± 1.18  2.44 ± 1.77  1.24 ± 0.64  1.86 ± 0.96 
Ficoll  6.33 ± 0.082  9.71 ± 0.13  1.32 ± 0.49  1.92 ± 0.71  0.88 ± 0.35  1.37 ± 0.54 
 
 
  
Table 3. Diffusion coefficients of neutral, positive and negatively charged dextran.  
D
ex
tr
an
 
M
o
le
cu
le
s 
Diffusion in Solution Transscleral Diffusion 
Diffusion 
coefficient ± 
SD, 20°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 37°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 20°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 37°C  
(x10-7 cm2s-1) 
Permeability 
coefficient ± 
SD, 20°C  
(x10-6 cm2s-1) 
Permeability 
coefficient ± 
SD, 20°C  
(x10-6 cm2s-1) 
Neutral  4.01 ± 0.065  6.15 ± 0.10  1.63 ± 1.18  2.44 ± 1.77  1.24 ± 0.64  1.86 ± 0.96 
Positive  4.74 ± 1.71  7.27 ± 2.62  3.44 ± 1.76  3.44 ± 1.76  1.59 ± 0.84  2.44 ± 1.29 
Negative  4.13 ± 1.07  6.33 ± 1.64  1.20 ± 0.50  1.20 ± 0.50  0.53 ± 0.15 
  
0.79 ± 0.22 
 
 
 
 
Table 4. Diffusion coefficients of neutral, positive and negatively charged ficoll.  
F
ic
o
ll
  
 
M
o
le
cu
le
s 
Diffusion in Solution Transscleral Diffusion 
Diffusion 
coefficient ± 
SD, 20°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 37°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 20°C 
(x10-7 cm2s-1) 
Diffusion 
coefficient ± 
SD, 37°C  
(x10-7 cm2s-1) 
Permeability 
coefficient ± 
SD, 20°C  
(x10-6 cm2s-1) 
Permeability 
coefficient ± 
SD, 20°C  
(x10-6 cm2s-1) 
Neutral  6.33 ± 0.082  9.71 ± 0.13  1.32 ± 0.49  1.92 ± 0.71  0.88 ± 0.35  1.37 ± 0.54 
Positive  6.32 ± 2.3  9.69 ± 3.53  0.49 ± 0.18  0.73 ± 0.27  0.43 ± 0.19  0.62 ± 0.27 
Negative  5.97 ± 0.57  9.15 ± 0.87  6.12 ± 2.16  9.29 ± 3.28  4.38 ± 1.58  6.81 ± 2.46 
 
 
 
 
Table 5. Zeta potentials for ficoll and dextran in the three electronic states 
Sample Zeta potential (mV) 
Neutral ficoll -4.79 ± 2.05 
Positive ficoll 7.31 ± 0.639 
Negative ficoll -11.2 ± 1.28 
Neutral dextran -2.68 ± 0.561 
Positive dextran 8.86 ± 0.393 
Negative dextran -11.6 ± 0.404 
 
 
FIGURES 
 
 
 
 
a 
b 
c 
 
d 
Photobleach 
F
lu
o
re
sc
en
ce
 I
n
te
n
si
ty
 
Time 
F1 
F∞ 
F0 0 20 40 60 80 100 1200.65
0.70
0.75
0.80
0.85
0.90
0.95
1.00
1.05
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
Time (s)
Figure 1. Schematic of fluorescence recovery after photobleaching (FRAP) curve. 
Figure 2. Diffusion coefficients of albumin versus viscosity  
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Figure 3. Diffusion coefficients in solution and sclera. 
 
Figure 4 Permeability coefficients in sclera. 
  
  
